Sabine Schuster

974 total citations
21 papers, 737 citations indexed

About

Sabine Schuster is a scholar working on Molecular Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Sabine Schuster has authored 21 papers receiving a total of 737 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Medicine, 12 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in Sabine Schuster's work include Antibiotic Resistance in Bacteria (16 papers), Cancer therapeutics and mechanisms (7 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Sabine Schuster is often cited by papers focused on Antibiotic Resistance in Bacteria (16 papers), Cancer therapeutics and mechanisms (7 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Sabine Schuster collaborates with scholars based in Germany, Netherlands and Switzerland. Sabine Schuster's co-authors include Winfried V. Kern, Jürgen A. Bohnert, Martina Vavra, Heike von Baum, Markus A. Seeger, Klaas M. Pos, Rainer Trittler, John W. A. Rossen, Matthias Bauer and Elias Klemm and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Bacteriology.

In The Last Decade

Sabine Schuster

20 papers receiving 718 citations

Peers

Countries citing papers authored by Sabine Schuster

Since Specialization

Citations

This map shows the geographic impact of Sabine Schuster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabine Schuster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabine Schuster more than expected).

Fields of papers citing papers by Sabine Schuster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabine Schuster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabine Schuster. The network helps show where Sabine Schuster may publish in the future.

Co-authorship network of co-authors of Sabine Schuster

This figure shows the co-authorship network connecting the top 25 collaborators of Sabine Schuster. A scholar is included among the top collaborators of Sabine Schuster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabine Schuster. Sabine Schuster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Frequent high-level rifaximin resistance in Escherichia coli associated with long-term treatment of patients with liver cirrhosis: a prospective, controlled study 2025 ·Microbiology Spectrum ·(unknown), Winfried V. Kern, Sabine Schuster, Michael Schultheiß, Christian Schneider, Martina Vavra, Robert Thimme, Siegbert Rieg, (unknown)	0
2	Comparative reassessment of AcrB efflux inhibitors reveals differential impact of specific pump mutations on the activity of potent compounds 2024 ·Microbiology Spectrum ·Sabine Schuster, Martina Vavra, (unknown), Winfried V. Kern	3
3	A Screening of Antimalarials Extends the Range of Known Escherichia coli AcrB Efflux Substrates and Reveals Two Candidates with Antimicrobial Drug-Enhancing Activity 2022 ·Microbial Drug Resistance ·Sabine Schuster, Martina Vavra, Winfried V. Kern	3
4	Limited Multidrug Resistance Efflux Pump Overexpression among Multidrug-Resistant Escherichia coli Strains of ST131 2021 ·Antimicrobial Agents and Chemotherapy ·(unknown), Sabine Schuster, Martina Vavra, (unknown), John W. A. Rossen, Sandra Reuter, Winfried V. Kern	15
5	Exploring the Contribution of the AcrB Homolog MdtF to Drug Resistance and Dye Efflux in a Multidrug Resistant E. coli Isolate 2021 ·Antibiotics ·Sabine Schuster, Martina Vavra, (unknown), Winfried V. Kern	10
6	New Topoisomerase Inhibitors: Evaluating the Potency of Gepotidacin and Zoliflodacin in Fluoroquinolone-Resistant Escherichia coli upon tolC Inactivation and Differentiating Their Efflux Pump Substrate Nature 2020 ·Antimicrobial Agents and Chemotherapy ·Sabine Schuster, Martina Vavra, (unknown), John W. A. Rossen, Winfried V. Kern	11
7	Efflux-Mediated Resistance to New Oxazolidinones and Pleuromutilin Derivatives in Escherichia coli with Class Specificities in the Resistance-Nodulation-Cell Division-Type Drug Transport Pathways 2019 ·Antimicrobial Agents and Chemotherapy ·Sabine Schuster, Martina Vavra, Winfried V. Kern	11
8	Proof of an Outer Membrane Target of the Efflux Inhibitor Phe-Arg-β-Naphthylamide from Random Mutagenesis 2019 ·Molecules ·Sabine Schuster, Jürgen A. Bohnert, Martina Vavra, John W. A. Rossen, Winfried V. Kern	21
9	Coupled Production of Steel and Chemicals 2018 ·Chemie Ingenieur Technik ·Michael L. Bender, (unknown), (unknown), Sabine Schuster, E. Schwab	18
10	Contribution of AcrAB-TolC to multidrug resistance in an Escherichia coli sequence type 131 isolate 2017 ·International Journal of Antimicrobial Agents ·Sabine Schuster, Martina Vavra, (unknown), John W. A. Rossen, Yasufumi Matsumura, Winfried V. Kern	27
11	A continuous sirtuin activity assay without any coupling to enzymatic or chemical reactions 2016 ·Scientific Reports ·Sabine Schuster, Claudia Roessler, Marat Meleshin, (unknown), (unknown), Christian Kambach, Cordelia Schiene‐Fischer, Clemens Steegborn, Michael O. Hottiger, Mike Schutkowski	28
12	Novel Piperazine Arylideneimidazolones Inhibit the AcrAB-TolC Pump in Escherichia coli and Simultaneously Act as Fluorescent Membrane Probes in a Combined Real-Time Influx and Efflux Assay 2016 ·Antimicrobial Agents and Chemotherapy ·Jürgen A. Bohnert, Sabine Schuster, Winfried V. Kern, Tadeusz Karcz, Agnieszka Olejarz‐Maciej, (unknown), Jadwiga Handzlik, Katarzyna Kieć‐Kononowicz	35
13	Evidence of a Substrate-Discriminating Entrance Channel in the Lower Porter Domain of the Multidrug Resistance Efflux Pump AcrB 2016 ·Antimicrobial Agents and Chemotherapy ·Sabine Schuster, Martina Vavra, Winfried V. Kern	34
14	Pimozide Inhibits the AcrAB-TolC Efflux Pump in Escherichia coli 2013 ·The Open Microbiology Journal ·Jürgen A. Bohnert, Sabine Schuster, Winfried V. Kern	21
15	The Role of Pd²⁺/Pd⁰ in Hydrogenation by [Pd(2‐pymo)₂]_n: An X‐ray Absorption and IR Spectroscopic Study 2012 ·Chemistry - A European Journal ·Sabine Schuster, Elias Klemm, Matthias Bauer	20
16	Determination of Real-Time Efflux Phenotypes in Escherichia coli AcrB Binding Pocket Phenylalanine Mutants Using a 1,2′-Dinaphthylamine Efflux Assay 2011 ·PLoS ONE ·Jürgen A. Bohnert, Sabine Schuster, (unknown), Winfried V. Kern	35
17	Efflux inhibition by selective serotonin reuptake inhibitors in Escherichia coli 2011 ·Journal of Antimicrobial Chemotherapy ·Jürgen A. Bohnert, (unknown), Sabine Schuster, Winfried V. Kern	85
18	Site-Directed Mutagenesis Reveals Putative Substrate Binding Residues in the Escherichia coli RND Efflux Pump AcrB 2008 ·Journal of Bacteriology ·Jürgen A. Bohnert, Sabine Schuster, Markus A. Seeger, (unknown), Klaas M. Pos, Winfried V. Kern	112
19	Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF) 2006 ·Journal of Antimicrobial Chemotherapy ·Jürgen A. Bohnert, Sabine Schuster, (unknown), Rainer Trittler, Winfried V. Kern	71
20	Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli 2005 ·Journal of Antimicrobial Chemotherapy ·Winfried V. Kern, (unknown), (unknown), Sabine Schuster, Heike von Baum, Jürgen A. Bohnert	142

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact